Direct answer
Countries should prioritize digital health investments by ranking the health problem first, then testing each proposed intervention against readiness, interoperability, equity, governance, financing and evidence. The strongest investment is not the newest tool. It is the one a health system can own, connect, monitor and sustain.
This article is educational analysis for strategy, product and implementation teams. It is not clinical, legal, regulatory or procurement advice. Country teams should use qualified review before making decisions about specific tools, medical-device claims, patient data, contracts or financing.
The urgency is real. The WHO global digital health strategy has been extended while a successor strategy is prepared, and the World Bank's Digital-in-Health work pushes governments to move beyond isolated digitization. But urgency can make portfolios messy. Ministries, donors and vendors may all arrive with useful ideas, while the system lacks a common way to decide what deserves scarce attention.
Think in portfolios, not projects
A country does not need one digital health project. It needs a balanced portfolio. Some investments are foundations: identity, registries, governance, connectivity, cybersecurity, workforce capability, data standards and architecture. Some are service improvements: appointment systems, telehealth, remote monitoring, laboratory reporting or supply chain visibility. Others are innovation bets that need controlled pilots before scale.
The portfolio view prevents two common mistakes. The first is funding only visible apps while the foundational work remains weak. The second is funding foundations forever without showing service value. A practical roadmap should include quick wins, infrastructure work and scale decisions, with each category judged by different evidence.
World Bank materials frame digital health around prioritizing, connecting and scaling. That is a useful order. A country that funds many standalone tools before it can connect them may get activity without system value. A country that connects data without solving real health-service problems may get architecture without trust.
Start with health need and user burden
Begin with the health problem, not the technology. What service gap is the investment meant to improve? Which patients, workers and facilities are affected? What evidence shows the gap? What current workflow is failing? If the answer is vague, the digital intervention will inherit the vagueness.
Needs should be ranked with users in the room. A central team may see reporting delays; a clinic may see duplicate data entry; patients may see travel cost, language barriers or missed follow-up. Prioritization improves when each group can describe what the investment would change in ordinary work.
Do not mistake demand from a pilot site for national value. A tool may be popular because it reduces work for one programme while increasing work elsewhere. It may fit an urban hospital and fail in a rural facility with poor connectivity. The right question is not only whether users like it, but whether the system can use it fairly and routinely.
Score readiness, architecture and ownership
Readiness is more than procurement permission. Countries should score whether the intervention has an institutional owner, policy alignment, a data map, infrastructure, support capacity, training plan, budget path and decision rights. If those pieces are missing, the investment may still be worth a pilot, but it should not be described as ready to scale.
Architecture matters because digital health fragmentation becomes expensive. A patient-facing service may need identity, consent, scheduling, records, payment, reporting and analytics. If each programme buys separate software with separate data models, the country later pays to reconcile decisions that should have been made at portfolio level.
The WHO Global Digital Health Monitor is useful here because it turns strategy and investment maturity into observable questions. Does a country have a digital health strategy? Is there a costed plan? Is funding structured? Are national priorities supported by scaled systems? The answers will vary, but the habit of measuring maturity helps avoid optimistic roadmaps.
A readiness score should also distinguish national foundations from programme-specific readiness. A country may have a digital strategy and still lack the facility connectivity needed for a remote-care service. A programme may have donor support and still lack a long-term institutional owner. Ranking should show those differences instead of averaging them into one comforting number.
Architecture review should happen before vendor selection, not after contracts are signed. The team should know which registries, identifiers, terminology standards, hosting rules, analytics needs and cybersecurity controls are non-negotiable. Otherwise each procurement creates its own architecture by accident, and the country later has to integrate a portfolio that was never designed to connect.
Make equity and trust ranking criteria
Digital health investments can expand access, but they can also move burden to people with the least margin. A telehealth service that assumes private smartphones, stable broadband, digital literacy and quiet rooms may exclude the same communities it is meant to reach. A data platform that improves reporting but doubles frontline entry work may weaken trust among health workers.
Equity should be scored before scale. Which groups may be left out? What languages are needed? What happens offline? Can disabled users access the service? Who pays for data, devices and travel? What support is available when the digital path fails? A tool should not receive a high priority score if it performs well only for the easiest users.
Trust is equally practical. Patients and workers need to understand what data is collected, how it is used, who can see it and what recourse exists when something goes wrong. Investment in privacy, security and communication is not overhead. It is part of adoption and safety.
Tie financing to evidence and scale gates
Financing should follow a staged evidence path. Early funding may test feasibility and workflow fit. Later funding should require stronger evidence on service outcomes, equity, costs, operational burden and sustainability. A pilot should have scale gates before it starts, not after a positive slide deck appears.
Costing needs to include the unglamorous pieces: training, support, hosting, cybersecurity, monitoring, help desk, integration, change management, device replacement and governance meetings. A digital health investment can look cheap when software is counted and institutional ownership is ignored. It becomes expensive when nobody budgeted for routine operation.
Procurement teams can support prioritization by asking for evidence that matches the maturity of the decision. Early discovery may need user research and workflow mapping. A pilot may need feasibility, safety and adoption evidence. National scale may need stronger proof of interoperability, total cost, service impact, support capacity and equity monitoring. The evidentiary bar should rise with the size of the commitment.
Countries should also reserve money for learning. A roadmap that funds only implementation has no room to improve after the first problems appear. Evaluation, maintenance and adaptation should be line items, not leftovers. Digital health systems touch clinical work, public trust and public budgets, so the ability to learn is part of the investment.
Exit criteria are part of responsible investment. Stop, pause or redesign when data quality is poor, safety concerns emerge, integration fails, equity gaps widen or staff workload becomes unreasonable. The best countries will not be those that fund the most pilots. They will be those that can say no, sequence work and move proven interventions into owned infrastructure.
For related analysis, read mHealth Zone's guide to the governance gap after digital health pilots or explore executive webinars for teams working through strategy and evidence questions.
FAQ
What should be prioritized first in digital health?
Prioritize problems with clear health-system value, known users, implementation ownership, data governance and a realistic path to scale.
Should countries fund many pilots?
Pilots can be useful, but a country portfolio should avoid fragmented tools that cannot connect to strategy, budgets or routine workflows.
Is this medical or procurement advice?
No. This is educational analysis for strategy teams and does not replace qualified clinical, regulatory, legal or procurement review.
Sources consulted: WHO Global strategy on digital health, World Bank Digital-in-Health report, World Bank Digital Health Blueprint Toolkit, WHO Global Digital Health Monitor, WHO Executive Board 2025 strategy-extension decision. Featured image: existing site asset, /assets/img/photo-hero.jpg.